April 6 (Reuters) - Eurobio Scientific SA ALERS.PA :
* 2021 TOTAL TURNOVER OF EUR 184.7M
* END-2021 CASH POSITION AT EUR 102M AND DECREASE IN
FINANCIAL
DEBT (EUR 11M)
* FY STRONG EBITDA AT EUR 78M
* NOW HAS VERY SIGNIFICANT FINANCIAL RESOURCES TO CONTINUE
TO
DEPLOY ITS STRATEGY
* HAS RENEWED NON-EXCLUSIVE PARTNERSHIP WITH KOREAN GROUP
SEEGENE,
AT LEAST UNTIL 2023, AND SIGNED DISTRIBUTION PARTNERSHIPS IN NEW
AREAS
* HAS THUS RENEWED ITS NON-EXCLUSIVE PARTNERSHIP WITH KOREAN
GROUP
SEEGENE, AT LEAST UNTIL 2023, AND SIGNED DISTRIBUTION
PARTNERSHIPS IN NEW AREAS
* FY NET RESULT EUR 60.5 MILLION VERSUS EUR 73.5 MILLION
YEAR AGO
Source text for Eikon: ID:nGNE1sqdGg
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))